- 379. Hiligsmann M, Cooper C, Guillemin F, Hochberg MC, Tugwell P, Arden N, Berenbaum F, Boers M, Boonen A, Branco JC, Maria-Luisa B, Bruyere O, Gasparik A, Kanis JA, Kvein TK, Martel-Pelletier J, Pelletier JP, Pinedo-Viallanueva R, Pinto D, Reiter-Neisert S, Rizzoli R, Rovati LC, Severens JL, Silverman S, Reginster JY: A reference case for economic evaluations in osteoarthritis: an expert consensus article from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Semin Arthritis Rheum 2014;44:271-82. [Epub 2014 Jun 27].
- 380. Dworkin RH, Turk DC, Peirce-Sandner S, He H, McDermott MP, Hochberg MC, Jordan JM, Katz NP, Lin AH, Neogi T, Rappaport BA, Simon LS, Strand V: Meta-analysis of assay sensitivity and study features in clinical trials of pharmacologic treatments for osteoarthritis pain. Arthritis Rheumatol 2014;66:3327-36.
- 381. He X, Whitmore GA, Loo GY, Hochberg MC, Lee ML: A model for time to fracture with a shock stream superimposed on progressive degradation: the Study of Osteoporotic Fractures. Stat Med 2015;34(4):652-63.
- 382. Zhang FF, Driban JB, Lo GH, Price LL, Booth S, Eaton CB, Lu B, Nevitt M, Jackson B, Garganta C, Hochberg MC, Kwoh K, McAlindon TE: Vitamin D deficiency is associated with progression of knee osteoarthritis. J Nutr 2014;144:2002-8.
- 383. Hochberg MC: Serious joint-related adverse eents in randomized controlled trials of anti- nerve growth factor monoclonal antibodies. Osteoarthritis Cart 2015;23 (Suppl 1):S18- 21, 2015.
- 384. Bellamy N, Hochberg M, Tubach F, Martin-Mola E, Awada H, Bombardier C, Hajjaj- Hassouni N, Logeart I, Matucci-Cerinic M, van de Laar M, van der Heijde D, Dougados M: Development of multinational definitions of minimal clinically important improvement and patient acceptable symptomatic state in osteoarthritis. Arthritis Care Res 2015;67(7):972-80.
- 385. Hochberg MC, Martel-Pelletier J, Monfort J, Moller I, Castillo JR, Arden N, Berenbaum F, Blanco FJ, Conaghan PG, Domenech G, Henrotin Y, Pap T, Richette P, Sawitzke A, du Souich P, Pelletier JP, on behalf of the MOVES Investigation Group: Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicenter, randomized, double-blind, non-inferiority trial vesus celecoxib. Ann Rheum Dis 2016;75(1):37-44.
- 386. Cutolo M, Berenbaum F, Hochberg M, Punzi L, Reginster JY: Commentary on recent therapeutic guidelines for osteoarthritis. Semin Arthritis Rheum 2015;44(6):611-7.
- 387. Bruyere O, Cooper C, Arden N, Branco J, Brandi ML, Herrero-Beaumont G, Berenbaum F, Dennison E, Devogelaer JP, Hochberg M, Kanis J, Laslop A, McAlindon T, Reiter S, Richette P, Rizzoli R, Reginster JY: Can we identify patients with high risk of osteoarthritis progression who will respond to treatment? A focus on epidemiology and phenotype of osteoarthritis. Drugs Aging 2015;32(3):179-87.
- 388. Reginster JY, Cooper C, Hochberg M, Pelletier JP, Rizzoli R, Kanis J, Abadie E, Maheu E, Brandi ML, Devogelaer JP, Branco J, Herrero- Beumont G, D'Hooghe P, Bruyere O: Comments on the discordant recommendations for the use of symptomatic slow-acting drugs in knee osteoarthritis. Curr Med Res Opin 2015;31(5):1041-5.
- 389. Solomon DH, Reed G, Kremer JM, Curtis JR, Farkouh ME, Harrold LR, Hochberg MC, Tsao P, Greenberg J: Disease activity in rheumatoid arthritis and the risk of cardiovascular events. Arthritis Rheumatol 2015;67(6):1449-55.